Establishment of a Bioequivalence-Indicating Dissolution Specification for Candesartan Cilexetil Tablets Using a Convolution Model

Hassan Ali Hassan (1) Naseem Ahmad Charoo (2) Areeg Anwer Ali (3) and Sumaiya Ser Alkhatem (4)

首页> 外文期刊>Dissolution technologies >Establishment of a Bioequivalence-Indicating Dissolution Specification for Candesartan Cilexetil Tablets Using a Convolution Model

【24h】

Establishment of a Bioequivalence-Indicating Dissolution Specification for Candesartan Cilexetil Tablets Using a Convolution Model

机译：使用卷积模型建立坎地沙坦Cilexetil片的生物等效性指示溶出度规范

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Dissolution technologies》 |2015年第1期|共8页
作者
Hassan Ali Hassan (1) Naseem Ahmad Charoo (2) Areeg Anwer Ali (3) and Sumaiya Ser Alkhatem (4);
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类药物分析;
关键词

相似文献

外文文献
中文文献
专利

1. DEVELOPMENT AND VALIDATION OF HPLC ANALYTICAL METHODS USED FOR DETERMINATION OF ASSAY, CONTENT UNIFORMITY AND DISSOLUTION OF IMMEDIATE RELEASE CANDESARTAN CILEXETIL 32 MG TABLETS [J] . MERAL YUCE Acta Poloniae Pharmaceutica: Durg Research . 2017,第2期

机译：用于测定测定的HPLC分析方法的开发和验证，即时释放糖果楸32mg片剂的立即释放和溶解
2. Justification of Drug Product Dissolution Rate and Drug Substance Particle Size Specifications Based on Absorption PBPK Modeling for Lesinurad Immediate Release Tablets [J] . Pepin Xavier J. H., Flanagan Talia R., Holt David J., Molecular pharmaceutics . 2016,第9期

机译：基于Lesinurad速释片吸收PBPK模型的药物溶解速率和药物颗粒尺寸规格的合理性
3. Establishment of a clinically relevant specification for dissolution testing using physiologically based pharmacokinetic (PBPK) modeling approaches [J] . European journal of pharmaceutics and biopharmaceutics: official journal of Arbeitsgemeinschaft fuer Pharmazeutische Verfahrenstechnik e.V . 2020,第期

机译：使用生理基础的药代动力学（PBPK）建模方法建立临床相关规范的溶出试验
4. LONG TERM STABILITY OF CANDESARTAN CILEXETIL AFTER MICRONIZATION [C] . Anna Maria Alves de Piloto Fernandes, Marcel Menezes, Phellipe Honorio Amaral, International Mass Spectrometry Conference . 2018

机译：微粉化后Candesartan Cilexetil的长期稳定性
5. 1. Development of hot-melt pan-coating, application to sustained-release capsules and tamper resistant-coating. 2. Formulation of verapamil hydrogen chloride and diltiazem hydrogen chloride semisolid matrix capsules. 3. Novel sustained release tablet of glipizide: Compression of coated drug beads, formulation, dissolution, and convolution. 4. Verapamil sustained release: New formulation and convolution. [D] . Nguyen, Chien Ngoc. 2006

机译：1.开发热熔性包衣，应用于缓释胶囊和防篡改包衣。 2.配制维拉帕米氯化氢和地尔硫卓氯化氢半固体基质胶囊。 3.格列吡嗪的新型缓释片剂：包衣药物珠的压缩，制剂，溶解和卷积。 4.维拉帕米缓释剂：新配方和卷积剂。
6. New simple spectrophotometric method for determination of the binary mixtures (atorvastatin calcium and ezetimibe; candesartan cilexetil and hydrochlorothiazide) in tablets [O] . Tarek S. Belal, Hoda G. Daabees, Magdi M. Abdel-Khalek, 2013

机译：新的简单分光光度法测定片剂中的二元混合物（阿托伐他汀钙和依折麦布；坎地沙坦西拉克司和氢氯噻嗪）
7. Evaluation of the Discriminatory Power of USP Dissolution Method for Candesartan Cilexetil Tablets through Testing of Marketed Products in Egypt [O] . Ahmed M. Amer, Ahmed N. Allam, Ossama Y. Abdallah 2018

机译：通过在埃及市售产品测试中评价USP溶解方法的歧视性能

Establishment of a Bioequivalence-Indicating Dissolution Specification for Candesartan Cilexetil Tablets Using a Convolution Model

著录项

相似文献

相关主题

期刊订阅